Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

U.S. Navy Band ‘Cruisers’ to Perform Free Concerts in CT, PA, and DE

April 28, 2026

TAWANI Enterprises, Inc. Earns Bronze Stevie Recognition in the American Business Awards

April 28, 2026

Carter Development Group Announces the Carter MEI Pillars™ as a National Standard for Merit-Based Governance and Compliance

April 28, 2026

Ernest and Evelyn Rady Commit $75 Million to Scripps Health

April 28, 2026

Remitsy Announces Rebrand to Wevia

April 28, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Aquaculture Vaccines Market Research 2024 – Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2029F
Press Release

Aquaculture Vaccines Market Research 2024 – Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2029F

By News RoomAugust 28, 20244 Mins Read
Aquaculture Vaccines Market Research 2024 – Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2029F
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) — The “Aquaculture Vaccines Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F” report has been added to ResearchAndMarkets.com’s offering.

Global Aquaculture Vaccines Market was valued at USD 379.49 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.75% through 2029

The Global Aquaculture Vaccines Market is a dynamic sector within the broader pharmaceutical and aquaculture industries, characterized by innovative research, technological advancements, and a growing emphasis on sustainable aquaculture practices. As the demand for seafood continues to rise globally, the aquaculture sector faces increasing challenges such as disease outbreaks, environmental concerns, and regulatory scrutiny. In response, the market for aquaculture vaccines has emerged as a crucial component in promoting the health and productivity of farmed fish and shellfish.

These vaccines are designed to prevent or mitigate the impact of infectious diseases that can devastate aquaculture stocks, leading to significant economic losses for producers. Key players in the global aquaculture vaccines market invest heavily in research and development to create effective and safe vaccine formulations tailored to the specific needs of various aquatic species, including salmon, trout, tilapia, shrimp, and others. The market encompasses a wide range of vaccine types, including inactivated vaccines, live attenuated vaccines, recombinant vaccines, and DNA vaccines, each offering distinct advantages in terms of efficacy, safety, and ease of administration.

Advancements in vaccine delivery technologies, such as oral vaccines and nanoparticle-based formulations, hold promise for enhancing vaccine efficacy and reducing environmental impact. For instance, In a recent study published in the Animals Journal, a group of researchers evaluated the efficacy of a bivalent vaccine against Aeromonas hydrophila (A. hydrophila) and Streptococcus agalactiae (S. agalactiae) in Nile tilapia through both laboratory and large-scale field tests in Brazil.

Geographically, the market for aquaculture vaccines is highly diverse, with significant growth opportunities in regions with expanding aquaculture industries, such as Asia-Pacific, Latin America, and Europe. Factors driving market growth include increasing aquaculture production, rising awareness of disease prevention strategies, and stringent regulatory requirements for food safety and environmental sustainability. However, challenges such as high development costs, regulatory hurdles, and public perception issues regarding vaccine use in aquaculture remain significant barriers to market expansion.

Key Market Trends

Increasing Aquaculture Production

The global aquaculture vaccines market is experiencing a significant boost due to the increasing production of farmed fish and shellfish worldwide. With the demand for seafood rising steadily, aquaculture has emerged as a crucial source to meet this demand, outpacing traditional wild-caught fisheries. This shift towards aquaculture production is driven by various factors, including population growth, changing dietary preferences, and the depletion of wild fish stocks.

As aquaculture production expands to keep pace with the growing demand, the industry faces numerous challenges, particularly concerning disease management. Crowded aquaculture environments, intensive production systems, and the movement of fish between farms create ideal conditions for the rapid spread of infectious diseases among aquatic species. Common pathogens such as bacteria, viruses, parasites, and fungi pose significant threats to the health and productivity of farmed fish and shellfish, resulting in substantial economic losses for aquaculture producers.

Regulatory Support and Industry Collaboration

Industry collaboration is a key driver behind the growth of the global aquaculture vaccines market. Stakeholders including vaccine manufacturers, aquaculture producers, research institutions, government agencies, and non-governmental organizations (NGOs) collaborate closely to address common challenges, share knowledge and resources, and accelerate vaccine development and adoption. Collaborative initiatives such as research consortia, public-private partnerships, and industry associations facilitate information exchange, precompetitive research, and joint funding opportunities, driving innovation and promoting best practices in aquaculture vaccination.

Industry collaboration enables stakeholders to pool their expertise and resources to address emerging disease threats and develop effective solutions tailored to the specific needs of different aquatic species and production systems. By working together, stakeholders can leverage economies of scale, optimize research and development efforts, and overcome barriers to market entry, ultimately driving market growth and expanding access to aquaculture vaccines globally.

Key Attributes:

Report Attribute Details
No. of Pages 183
Forecast Period 2024 – 2029
Estimated Market Value (USD) in 2024 $379.49 Million
Forecasted Market Value (USD) by 2029 $588.2 Million
Compound Annual Growth Rate 7.7%
Regions Covered Global

Report Scope:

Key Market Players

  • Zoetis Inc.
  • Phibro Animal Health Corporation
  • Elanco Animal Health Incorporated
  • Merck KGaA
  • KBNP Inc.
  • UNILINE GROUP FOR VETERINARY EQUIPMENT
  • Kyoto Biken Laboratories, Inc.
  • Nisseiken Co., Ltd.
  • Vaxxinova International BV
  • HIPRA SA

Aquaculture Vaccines Market, By Product:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Aquaculture Vaccines Market, By Route of Administration:

  • Oral
  • Injected
  • Immersion & Spray

Aquaculture Vaccines Market, By Application:

Aquaculture Vaccines Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

For more information about this report visit https://www.researchandmarkets.com/r/fd5vd6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Aquaculture Vaccines Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

U.S. Navy Band ‘Cruisers’ to Perform Free Concerts in CT, PA, and DE

TAWANI Enterprises, Inc. Earns Bronze Stevie Recognition in the American Business Awards

Carter Development Group Announces the Carter MEI Pillars™ as a National Standard for Merit-Based Governance and Compliance

Ernest and Evelyn Rady Commit $75 Million to Scripps Health

Remitsy Announces Rebrand to Wevia

Containerized Data Center Market Report 2026: Analysis and Forecast Through 2020-2030 & 2035

Trends and Strategies in the 2026 Medical Device CMDO Market: Revenue to Exceed $354 Billion by 2033

Otus Honored as a Gold Stevie® Award Winner for AI Breakthrough of the Year in the 2026 American Business Awards®

EVIDENT Announces 6th Annual Image of the Year Award Winners

Editors Picks

TAWANI Enterprises, Inc. Earns Bronze Stevie Recognition in the American Business Awards

April 28, 2026

Carter Development Group Announces the Carter MEI Pillars™ as a National Standard for Merit-Based Governance and Compliance

April 28, 2026

Ernest and Evelyn Rady Commit $75 Million to Scripps Health

April 28, 2026

Remitsy Announces Rebrand to Wevia

April 28, 2026

Latest News

Containerized Data Center Market Report 2026: Analysis and Forecast Through 2020-2030 & 2035

April 28, 2026

Trends and Strategies in the 2026 Medical Device CMDO Market: Revenue to Exceed $354 Billion by 2033

April 28, 2026

Otus Honored as a Gold Stevie® Award Winner for AI Breakthrough of the Year in the 2026 American Business Awards®

April 28, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version